The NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib
This is a contract result notice, not an open opportunity. Details from the official award data.
The procurement contact named on the official notice.
Project title: invitation to offer for NHS National Pharmaceuticals – Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.
Make the case to bid
Reveal who to approach at The NHS Commissioning Board (operating under the name of NHS England), and generate a go-to-market strategy from their news, accounts and people.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-029839
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 004316-2021
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
The NHS Commissioning Board (operating under the name of NHS England)’s tender network
Assembling the network…